Skip to content
Stop using now Drug recall · FDA · Published June 6, 2014

Hospira Heparin Recall: Sterility Risk Due to Leaking Bags

Hospira recalls Heparin Sodium in 5% Dextrose Injection due to confirmed fluid leaking from bags, posing a sterility risk. Check lot numbers immediately.

🇺🇸 FDA recall #D-1425-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling specific lots of Heparin Sodium in 5% Dextrose Injection because there is a lack of assurance of sterility. This issue stems from a confirmed consumer report of fluid leaking from the primary container bag. The recall affects approximately 142,152 bags distributed nationwide. Read more at govinfonow.com/recall/46010-hospira-inc-recalls-heparin-sodium-in-5-dextrose-injection-heparin.

Source Summary by GovInfoNow · govinfonow.com/recall/46010-hospira-inc-recalls-heparin-sodium-in-5-dextrose-injection-heparin · Updated October 12, 2026 · FDA enforcement record: FDA #D-1425-2014

Cite this page

“Hospira Heparin Recall: Sterility Risk Due to Leaking Bags.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/46010-hospira-inc-recalls-heparin-sodium-in-5-dextrose-injection-heparin. Based on FDA recall #D-1425-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1425-2014%22&limit=1).

The FDA announced on June 6, 2014, that Hospira Inc. voluntarily recalled Heparin Sodium Injection due to a lack of sterility assurance confirmed by a consumer report of fluid leaking from the primary container bag. Owners should contact the company for a refund.

How to tell if you have it

  • Brand: Hospira
  • Product: Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container
  • NDC: 0409-7793-62
  • Lot codes: 34-811-KL, 36-106-KL, 36-114-KL, 36-101-KL, 37-202-KL, 38-302-KL, 38-305-KL
  • Expiration dates: 12/15, 1/16, 2/16
  • Quantity: 142,152 bags

The hazard

The recall addresses a lack of assurance of sterility caused by confirmed consumer reports of fluid leaking from the primary container bag, which poses an infection risk.

Context

GovInfoNow's records show Hospira Inc. has issued 108 other recalls since April 5, 2012. Other recent recalls include a 2017-04-21 recall for hair particulates in Infant Dextrose Injection and a 2016-11-01 recall for broken ampule tips on Fentanyl Injection. Additional similar product recalls include a 2026-03-11 Fresenius Kabi Sodium Chloride Injection recall for lack of sterility assurance and a 2026-04-24 Teva Octreotide Acetate Kit recall for sterility risk.

How to tell if you have this one

Check your product for the following details: Manufacturer Hospira Inc., NDC 0409-7793-62, Single-Dose Container. Verify the Lot Number and Expiration Date against this list: Lot # 34-811-KL (Exp. 12/15), 36-106-KL (Exp. 12/15), 36-114-KL (Exp. 12/15), 36-101-KL (Exp. 12/15), 37-202-KL (Exp. 1/16), 38-302-KL (Exp. 2/16), and 38-305-KL (Exp. 2/16).

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not administer or use any Heparin Sodium in 5% Dextrose Injection bags matching the recalled lot numbers.

  2. Contact your supplier

    Reach out to the pharmacy or healthcare facility where you obtained the medication to report the issue and request a replacement or refund.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

1. Firm started the recall: Jun 6, 201412. FDA classified it Class II: Jul 9, 201423. Published in FDA’s Enforcement Report: Jul 16, 201434. FDA terminated the recall: Apr 3, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1425-2014 (June 6, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1425-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA